Effects of ursodeoxycholic acid (UDCA) o
✍
E. Rolandi; R. Franceschini; A. Cataldi; V. Cicchetti; L. Carati; T. Barreca
📂
Article
📅
1991
🏛
Springer
🌐
English
⚖ 347 KB
The effects of ursodeoxycholic acid (UDCA, 450 mg daily) in patients with histologically proven chronic active hepatitis (CAH) have been evaluated in a randomized, double-blind, placebo-controlled study. Twenty-six patients with serum alanine aminotransferase (ALT) values at least twice the normal u